Auctus Fund Management LLC 13D and 13G filings for Guided Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 12:41 pm Purchase |
2024-09-30 | 13G | Guided Therapeutics, Inc. GTHP |
Auctus Fund Management LLC | 5,804,865 9.900% |
462,025 (+8.65%) |
Filing |
| 2024-02-14 1:48 pm Purchase |
2023-12-31 | 13G | Guided Therapeutics, Inc. GTHP |
Auctus Fund Management LLC | 5,342,840 9.900% |
397,043 (+8.03%) |
Filing |
| 2023-02-14 12:54 pm Purchase |
2022-12-31 | 13G | Guided Therapeutics, Inc. GTHP |
Auctus Fund Management LLC | 4,945,797 9.900% |
190,699 (+4.01%) |
Filing |
| 2022-10-24 4:17 pm Purchase |
2022-10-11 | 13G | Guided Therapeutics, Inc. GTHP |
Auctus Fund Management LLC | 4,755,098 9.900% |
4,755,098 (New Position) |
Filing |